Trevi stock tumbles 23 percent amid Haduvio study results

TRVI Stock  USD 3.60  1.11  44.58%   
Under 58% of all Trevi Therapeutics' traders are looking to take a long position. The analysis of overall sentiment of trading Trevi Therapeutics stock suggests that some investors are interested at this time. Trevi Therapeutics' investing sentiment shows overall attitude of investors towards Trevi Therapeutics.
  
Trevi Therapeutics stock tumbled 23 percent Tuesday post-market after the company reported results from a human abuse potential study of its drug Haduvio. Read more here.

Read at seekingalpha.com
seekingalpha News
  

Trevi Therapeutics Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Trevi Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Trevi Therapeutics Fundamental Analysis

We analyze Trevi Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Trevi Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Trevi Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Asset

Net Asset Comparative Analysis

Trevi Therapeutics is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Trevi Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Trevi Therapeutics stock to make a market-neutral strategy. Peer analysis of Trevi Therapeutics could also be used in its relative valuation, which is a method of valuing Trevi Therapeutics by comparing valuation metrics with similar companies.

Peers

Trevi Therapeutics Related Equities

ANEBAnebulo Pharmaceuticals   0.72   
0%
7.0%
SEERSeer   2.38   
26.0%
0%
CGEMCullinan Oncology   2.56   
28.0%
0%
CUECue Biopharma   3.67   
40.0%
0%
SPROSpero Therapeutics   4.35   
47.0%
0%
ANTXAN2 Therapeutics   4.52   
49.0%
0%
LYRALyra Therapeutics   4.76   
52.0%
0%
PRLDPrelude Therapeutics   5.32   
58.0%
0%
BOLTBolt Biotherapeutics   5.36   
58.0%
0%
ORICOric Pharmaceuticals   5.92   
65.0%
0%
RZLTRezolute   6.07   
66.0%
0%
TARAProtara Therapeutics   6.30   
69.0%
0%
FHTXFoghorn Therapeutics   6.47   
71.0%
0%
BCABBioatla   6.54   
71.0%
0%
CCCCC4 Therapeutics   8.28   
91.0%
0%
CHRSCoherus BioSciences   9.09   
100.0%
0%

Complementary Tools for Trevi Stock analysis

When running Trevi Therapeutics' price analysis, check to measure Trevi Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trevi Therapeutics is operating at the current time. Most of Trevi Therapeutics' value examination focuses on studying past and present price action to predict the probability of Trevi Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trevi Therapeutics' price. Additionally, you may evaluate how the addition of Trevi Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments